REDWOOD CITY, Calif., Aug. 24, 2017 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today announced that its management is scheduled to present at the following upcoming investor conferences:
Event: Wells Fargo 2017 Healthcare Conference Location: Boston, MA at the Westin Boston Waterfront Hotel Date: Thursday, September 7, 2017 Time: 10:35 a.m. ET / 7:35 a.m. PT
Event: Morgan Stanley Global Healthcare Conference Location: New York City, NY at the Grand Hyatt New York Hotel Date: Wednesday, September 13, 2017 Time: 11:05 a.m. ET / 8:05 a.m. PT
Each presentation will be accessible via a live audio webcast, accessible in the "Investors" section of the Company's website at: http://www.nevro.com/investors. Following each presentation, an archived copy will be available on the Investor Events and Presentations webpage of the Company's website.
Headquartered in Redwood City, California, Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. The Senza system is the only SCS system that delivers Nevro's proprietary HF10 therapy. Senza, HF10, Nevro and the Nevro logo are trademarks of Nevro.